173 related articles for article (PubMed ID: 808405)
1. [Mechanism of action of gliquidone (author's transl)].
Zilker T; Ermler R; Henderkott U; Bottermann P
Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
[TBL] [Abstract][Full Text] [Related]
2. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
3. [Influencing of blood sugar, serum insulin level and nonesterified fatty acids during continuous feeding following orally administered sulfonylurea compounds ARDF 26 and glibenclamide].
Zilker T; Waldthaler A; Lüders T; Ermler R; Bottermann P
Verh Dtsch Ges Inn Med; 1974; 80():1299-302. PubMed ID: 4217979
[No Abstract] [Full Text] [Related]
4. [Effect of gliquidone and glibenclamide following oral administration].
Ziler T; Waldthaler A; Ermler R; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
[TBL] [Abstract][Full Text] [Related]
5. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
Rizzi G; Isaia GC
Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
[No Abstract] [Full Text] [Related]
6. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
7. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
8. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
Herrlinger H; Dörfler H; Wolfram G; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
[No Abstract] [Full Text] [Related]
9. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
10. [Modern oral sugar-reducing drugs: focus to glibenclamide].
Ushakova EA
Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041
[No Abstract] [Full Text] [Related]
11. [Glisoxepide treatment in maturity-onset diabetics (author's transl)].
Happ J; Beyer J; Ulreich F; Schöffling K; Krause U; Frönlich A
Dtsch Med Wochenschr; 1976 Nov; 101(45):1643-6. PubMed ID: 1033056
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
13. Effect of glipizide on a double-meal test in diabetic patients.
Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
[No Abstract] [Full Text] [Related]
14. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
Willms B
MMW Munch Med Wochenschr; 1975 Oct; 117(41):1643-8. PubMed ID: 810689
[TBL] [Abstract][Full Text] [Related]
15. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
[No Abstract] [Full Text] [Related]
16. [Radioimmunological determination of insulin in patients with manifest diabetes mellitus as a guide for the planning of therapy (author's transl)].
Zilker T; Kränzlin T; Schweigart U; Ermler R; Bottermann P
Med Klin; 1976 Apr; 71(18):761-7. PubMed ID: 818495
[TBL] [Abstract][Full Text] [Related]
17. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
[No Abstract] [Full Text] [Related]
18. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
19. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
[No Abstract] [Full Text] [Related]
20. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
Marble A
Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
